It is no secret that in the context of corporate philanthropy in the field of health care, significant contributions are seen mostly as gestures aimed at helping create elite research facilities or private pavilions. For instance, the belief that when a famous billionaire decides to donate a large amount of money to a medical institution, his/her main purpose is to advance biomedical research becomes very popular.
But this conventional model completely overlooks the structural crises that local municipal health services face on a daily basis. Long before an urban community can benefit from advanced experimental therapies, its most vulnerable residents require a functional, heavily fortified safety-net system capable of delivering baseline emergency services, managing complex chronic illnesses, and providing compassionate primary care.
